PTH and hypercalcemia disease: Serum calcium levels also influence the use of specific therapies to address other laboratory levels such as serum PTH and phosphate, such that hypercalcemia favors the use of calcimimetics while hypocalcemia favors vitamin D therapies for PTH lowering (100%).